What Hims & Hers Health (HIMS) Said on Its Q3 Earnings Call

Hims & Hers (HIMS) Q3 2026 Earnings Call Transcript

International expansion offset a U.S. subscriber slowdown in the quarter.

What Hims & Hers Health (HIMS) Said on Its Q3 Earnings Call

Hims & Hers Health (NYSE:HIMS) reported third-quarter revenue growth of 49% but lost 100,000 subscribers from the prior quarter, as the digital health company held back U.S. weight-loss marketing and consolidated brands in international markets. Revenue rose to $890 million, while subscribers i

Hims & Hers anticipates Q4 revenue of $875M-$895M while preparing broader GLP-1 assortment and international marketing push

Hims & Hers cuts 2026 profit forecast as margins contract - Regional Media News

Nov 9 (Reuters) - Hims & Hers Health cut its full-year core profit forecast on Monday as higher costs tied to branded weight-loss drugs and international expansion pressured margins. Shares were down 2% in volatile after-hours trading. Growing weight-loss business and international expansion have helped [...]

Hims' 'Coaster Ride Continues With Surprise Losses, Sales Miss

Hims stock took a hit late Monday after the company reported surprise losses and issued a light guide for the year.

Hims & Hers Narrows Sales Outlook

The digital healthcare company narrowed its full-year revenue outlook after third-quarter sales came in lower than expected.